Archives: 2024-10-25

18-month data suggest myocarditis complications more common after COVID infection than vaccination

A study today in JAMA suggests that hospitalized patients—primarily previously healthy young men—have considerably fewer cardiovascular sequelae by 18 months if they develop myocarditis after COVID-19 mRNA vaccination than after COVID-19 infection. French researchers mined data from the French National Health Data System on all 4,635 residents aged 12 to 49 years hospitalized for myocarditis, or inflammation of the heart

Read More


At-home transcranial direct brain stimulation for depression is safe and effective, according to research from UTHealth Houston, King’s College London, and University of East London

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London. The research was published in Nature

Read More


Semaglutide, popular diabetes and weight-loss drug, may reduce risk of Alzheimer’s disease

Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). Alzheimer’s disease is a brain disorder that slowly destroys memory and thinking skills. According to the Alzheimer’s Association, nearly

Read More


Researchers at Imperial College London and Imperial College Healthcare NHS Trust publish an AI model able to predict health risks, including early death, from ECGs:

A new AI model can predict patients’ risk of developing and worsening disease, and even their risk of early death, using an electrocardiogram (ECG). Researchers at Imperial College London and Imperial College Healthcare NHS Trust believe their work, published today in Lancet Digital Health, could be used in the NHS within five years. It would

Read More


CLEC14A Protein blocking bone development could hold clues for future osteoporosis treatment

Researchers of University of Birmingham have shown that blood vessels produce a protein called CLEC14A that inhibits bone formation Scientists have identified a protein that blocks the activity of bone-forming cells (osteoblasts) by stopping them from maturing during the journey to sites of bone formation, a new study has found. In a paper published in Communications

Read More


Wider Use of Convalescent Plasma Might Have Saved Thousands More Lives During Pandemic

Authors say findings support considering convalescent plasma deployment for future infectious diseases emergencies A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients

Read More